Identification of the Most Accessible Sites to Ribozymes on the Hepatitis C Virus Internal Ribosome Entry Site

Journal of Biochemistry and Molecular Biology

Volumn 36, Issue 6, 2003, Pages 538-544

  Ryu, Kyung Ju ^a   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

Author keywords

Gene therapy; HCV; IRES; RNA mapping; Trans splicing ribozyme

Indexed keywords

COMPLEMENTARY RNA; RIBOZYME;

ARTICLE; GENE MAPPING; HEPATITIS C VIRUS; INTERNAL RIBOSOME ENTRY SITE; MEDICAL ASSESSMENT; PREDICTION; PROTEIN DOMAIN; PROTEIN TARGETING; RNA CLEAVAGE; RNA SEQUENCE; RNA SPLICING; VIRUS GENOME;

HEPATITIS C VIRUS;

EID: 0942289830     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: 10.5483/bmbrep.2003.36.6.538     Document Type: Article

References (36)

1. Been, M. and Cech, T. (1986) One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity. Cell 47, 207-216.
2. Bukh, J., Purcell, R. H. and Miller, R. H. (1992) Sequence analysis of 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 89, 4942-4946.
3. Choo, Q. -L. Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, A., Barr, P. J., Weiner, A. J., Bradley, D. W., Kuo, G. and Houghton, M. (1991) Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88, 2451-2455.
4. Chung, J. H., Park, H. -Y., Lee, J. H. and Jang, Y. (2002) Identification of the dITP-and XTP-hydrolyzing protein from Escherichia coli. J. Biochem. Mol. Biol. 35, 403-408.
5. Di Bisceglie, A. M., McHutchison, J. F. and Rice, C. M. (2002) New therapeutic strategies for hepatitis C. Hepatology 35, 224-231.
6. Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L. Jr., Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J. and Yu, J. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347, 975-982.
7. Hahm, B., Kim, Y. K., Kim, J. H., Kim, T. Y. and Jang, S. K. (1998) Heterogeneous nuclear ribonucleoprotein L interacts with the 3′ border of the internal ribosomal entry site of hepatitis C virus. J. Virol. 72, 8782-8788.
8. Hanecak, R., Browndriver, V., Fox, M. C., Azad, R. F., Furusako, S., Nozaki, C., Ford, C., Sasmor, H. and Anderson, K. P. (1996) Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol. 70, 5203-5212.
9. Honda, M., Beard, M. R., Ping, L. H. and Lemon, S. M. (1999) A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J. Virol. 73, 1165-1174.
10. Jones, J. T., Lee, S. -W. and Sullenger, B. A. (1996) Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2, 643-648.
11. Jones, J. T. and Sullenger, B. A. (1997) Evaluating and enhancing ribozyme reaction efficiency in mammalian cells. Nat. Biotechnol. 15, 902-905.
12. Kapadia, S. B., Brideau-Anderson, A. and Chisari, F. V. (2003) Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 2014-2018.
13. Kim, H. S. and Park, Y. S. (2002) Effect of lipid compositions on gene transfer into 293 cells using sendai F/HN-virosomes. J. Biochem. Mol. Biol. 35, 459-464.
14. Lan, N., Howrey, R. P., Lee, S. -W., Smith, C. A. and Sullenger, B. A. (1998) Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors. Science 280, 1593-1596.
15. Lan, N., Rooney, B. L., Lee, S. -W., Howrey, R. P., Smith, C. A. and Sullenger, B. A. (2000) Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2, 245-255.
16. Lauer, G. M. and Waker, B. D. (2001) Hepatitis C virus infection. N. Engl. J. Med. 345, 41-52.
17. Lieber, A., He, C. Y., Polyak, S. J., Gretch, D. R., Barr, D. and Kay, M. A. (1996) Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J. Virol. 70, 8782-8791.
18. Macejak, D. G., Jensen, K. L., Jamison, S. F., Domenico, K., Roberts, E. C., Chaudhary, N., von Carlowitz, I., Bellon, L., Tong, M. J., Conrad, A., Pavco, P. A. and Blatt, L. M. (2000) Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 31, 769-776.
19. Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M. and Albrecht, J. K. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958-965.
20. Miller, R. H. and Purcell, R. H. (1990) Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. USA 87, 2057-2061.
21. Phylactou, L. A., Darrah, C. and Wood, M. J. (1998) Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18, 378-381.
22. Randall, G., Grakoul, A, and Rice, C. M. (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 235-240.
23. Rogers, C. S., Vanoye, C. G., Sullenger, B. A. and George, Jr., A. L. (2002) Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J. Clin. Invest. 110, 1783-1798.
24. Rosenberg, S. (2001) Recent advances in the molecular biology of hepatitis C virus. J. Mol. Biol. 313, 451-464.
25. Ryu, K. -J., Kim, J. -H. and Lee, S. -W. (2003) Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7, 386-395.
26. Sakamoto, N., Wu, C. H. and Wu, G. Y. (1996) Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. J. Clin. Invest. 98, 2720-2728.
27. Shin, K. -S., Bae, S. -J., Hwang, E. -S., Jeong, S. and Lee, S. -W. (2002) Ribozyme-mediated replacement of p53 RNA by targeted trans-splicing. J. Microbiol. Biotechnol. 12, 844-848.
28. Sullenger, B. A. (1996) Ribozyme-mediated repair of RNAs encoding mutant tumor suppressors. Cytokines Mol. Ther. 2, 201-206.
29. Sullenger, B. A. and Cech, T. R. (1994) Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 317, 619-622.
30. Sullenger, B. A. and Gilboa, E. (2002). Emerging clinical applications of RNA. Nature 418, 252-258.
31. Wang, T. H., Rijnbrand, R. C. and Lemon, S. M. (2000) Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J. Virol. 74, 11347-11358.
32. Watanabe, T. and Sullenger, B. A. (2000) Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. USA 97, 8490-8494.
33. Welch, P. J., Tritz, R., Yei, S., Leavitt, M., Yu, M. and Barber, J. (1996) A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection. Gene Ther. 3, 994-1001.
34. Wilson, J. A., Jayasena, S., Khvorova, A., Sabatinos, S., Rodrigue-Gervais, I. G., Arya, S., Sarangi, F., Harris-Brandts, M., Beaulieu, S. and Richardson, C. D. (2003) RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. USA 100, 2783-2788.
35. Witherell, G. W. (2001) ISIS-14803 (ISIS Pharmaceuticals). Curr. Opin. Investig. Drugs. 2, 1523-1529.
36. World Health Organization. (1999) Global surveillance and control of hepatitis C. J Viral Hepat. 6, 35-47.